Biology of double-hit B-cell lymphomas

Current Opinion in Hematology

Volumn 19, Issue 4, 2012, Pages 299-304

  Lindsley, R Coleman ^a,b   Lacasce, Ann S ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

BCL2; BCL6; double hit; lymphoma; MYC

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; MYC PROTEIN; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; VINCRISTINE;

B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME ABERRATION; COPY NUMBER VARIATION; CYTOGENETICS; DOUBLE HIT B CELL LYMPHOMA; HUMAN; LARGE CELL LYMPHOMA; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; GENE REARRANGEMENT, B-LYMPHOCYTE; HUMANS; LYMPHOMA, B-CELL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-CBL; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT FUSION PROTEINS;

EID: 84862118460     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328353bbbd     Document Type: Review

References (36)

1. Bertrand P, Bastard C, Maingonnat C, et al. Mapping of MYC breakpoints in 8q24 rearrangements involving nonimmunoglobulin partners in B-cell lymphomas. Leukemia 2007; 21:515-523.
2. Johnson NA, Savage KJ, Ludkovski O, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood 2009; 114:2273-2279.
3. Kanungo A, Medeiros LJ, Abruzzo LV, Lin P. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Mod Pathol 2006; 19:25-33. (Pubitemid 43250976)
4. Le Gouill S, Talmant P, Touzeau C, et al. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92:1335-1342. (Pubitemid 350144150)
5. Macpherson N, Lesack D, Klasa R, et al. Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol 1999; 17:1558-1567.
6. Niitsu N, Okamoto M, Miura I, Hirano M. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia 2009; 23:777-783.
7. Tomita N. BCL2, MYC dual-hit lymphoma/leukemia. J Clin Exp Hematopathol 2011; 51:7-12.
8. Snuderl M, Kolman OK, Chen Y-B, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 2010; 34:327-340.
9. Salaverria I, Siebert R. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective. J Clin Oncol 2011; 29:1835-1843.
10. Aukema SM, Siebert R, Schuuring E, et al. Double-hit B-cell lymphomas. Blood 2011; 117:2319-2331.
11. Li S, Lin P, Fayad LE, Lennon PA, et al. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol 2012; 25:145-146.
12. Yoon SO, Jeon YK, Paik JH, et al. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Histopathology 2008; 53:205-217. (Pubitemid 352032771)
13. Foot NJ, Dunn RG, Geoghegan H, et al. Fluorescence in situ hybridisation analysis of formalin-fixed paraffin-embedded tissue sections in the diagnostic work-up of non-Burkitt high grade B-cell non-Hodgkin's lymphoma: a single centre's experience. J Clin Pathol 2011; 64:802-808.
14. Barrans S, Crouch S, Smith A, et al. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 2010; 28:3360-3365.
15. Stasik CJ, Nitta H, Zhang W, et al. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica 2010; 95:597-603.
16. Pasqualucci L, Trifonov V, Fabbri G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43:830-837.
17. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412:341-346. (Pubitemid 32691848)
18. Tomita N, Tokunaka M, Nakamura N, et al. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica 2009; 94:935-943.
19. Tibiletti MG, Martin V, Bernasconi B, et al. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome. Hum Pathol 2009; 40:645-652.
20. Bacher U, Haferlach T, Alpermann T, et al. Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms. Genes Chromosomes Cancer 2011; 50:43-50.
21. Kluin P, Harris N, Stein H, Leoncini L. B-cell lymphoma, unclassifiable, with features, intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, editors. WHO, Classification of tumours of haematopoietic, lymphoid tissues. 4th ed. Lyon, France: IARC Press; 2008. pp. 265-266.
22. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006; 354:2419-2430. (Pubitemid 43855045)
23. Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histonemodifying genes in non-Hodgkin lymphoma. Nature 2011; 476:298-303.
24. Choi S-Y, Kim SJ, Kim WS, et al. Aggressive B cell lymphomas of the gastrointestinal tract: clinicopathologic and genetic analysis. Virchows Arch 2011; 459:495-502.
25. Lu B, Zhou C, Yang W, et al. Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients. Leuk Lymphoma 2011; 52:2356-2364.
26. Oschlies I, Klapper W, Zimmermann M, et al. Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood 2006; 107:4047-4052. (Pubitemid 43726813)
27. Lin P, Dickason TJ, Fayad LE, et al. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Cancer 2012; 118:1566-1573.
28. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346:1937-1947. (Pubitemid 34651353)
29. Nogai H, Dörken B, Lenz G. Pathogenesis of non-Hodgkin's lymphoma. J Clin Oncol 2011; 29:1803-1811.
30. Hwang YY, Loong F, Chung LP, Chim CS. Atypical Burkitt's lymphoma transforming from follicular lymphoma. Diagn Pathol 2011; 6:63.
31. Kobayashi H, Ichikawa M, Hangaishi A, et al. Concurrent development of 'Burkitt-like' lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin. Int J Hematol 2011; 93:112-117.
32. Christie L, Kernohan N, Levison D, et al. C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: an adverse prognostic indicator? Leuk Lymphoma 2008; 49:470-476. (Pubitemid 351298330)
33. Johnson NA, Al-Tourah A, Brown CJ, et al. Prognostic significance of secondary cytogenetic alterations in follicular lymphomas. Genes Chromosomes Cancer 2008; 47:1038-1048.
34. Relander T, Johnson NA, Farinha P, et al. Prognostic factors in follicular lymphoma. J Clin Oncol 2010; 28:2902-2913.
35. Mohamed AN, Palutke M, Eisenberg L, Al-Katib A. Chromosomal analyses of 52 cases of follicular lymphoma with t (14; 18), including blastic/blastoid variant. Cancer Genet Cytogenet 2001; 126:45-51. (Pubitemid 32416525)
36. Vaidyanathan G, Ngamphaiboon N, Hernandez-Ilizaliturri FJ. Clinical spectrum and prognosis of follicular lymphoma with blastoid transformation: case series and a review of the literature. Ann Hematol 2011; 90:955-962.